Contract analysis

Section 1(a): Equity Financing For purposes of this SAFE, "Equity Financing" means a bona fide transaction or series of related transactions with the principal purpose of raising capital, pursuant to which the Company issues and sells shares of Preferred Stock of the Company at a fixed pre-money or post-money valuation, and in which the Company receives aggregate gross proceeds of not less than One Million Dollars ($

Section 1(b): Liquidity Event For purposes of this SAFE, "Liquidity Event" means a Change of Control (as defined in Section 2) or an Initial Public Offering (as defined in Section 2). If a Liquidity Event occurs before the termination of this SAFE pursuant to Section 1(d), the Investor shall have the right to elect, at its sole discretion, to receive either: (i) a cash payment from the Company (or, in the case of a C

Section 1(c): Dissolution Event For purposes of this SAFE, "Dissolution Event" means (i) a voluntary termination of operations by the Company, (ii) a general assignment for the benefit of the Company's creditors, or (iii) any other liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary; provided, however, that a Dissolution Event shall not include any transaction that constitutes a L

Section 1(d): Termination This SAFE will automatically terminate and be of no further force or effect (without relieving the Company of any obligations arising from a prior breach of, or non-compliance with, this SAFE prior to such termination) upon the earliest to occur of: (i) the issuance of shares of Standard Preferred Stock (or Common Stock, as applicable) to the Investor pursuant to Section 1(a) or Section 1(b)

Section 3(a): Organization, Good Standing, and Qualification The Company is a corporation duly organized, validly existing, and in good standing under the laws of the State of Delaware. The Company has all requisite corporate power and authority to own, lease, and operate its properties and assets, to carry on its business as currently conducted and as presently proposed to be conducted, and to enter into, deliver, a

Section 3(b): Authorization All corporate action on the part of the Company, its officers, directors, and stockholders necessary for the authorization, execution, delivery, and performance of all obligations of the Company under this SAFE, including the reservation and issuance of shares of Capital Stock upon conversion hereof, has been taken or will be taken prior to such issuance. This SAFE, when executed and deliv

Section 3(c): Compliance with Other Instruments The execution, delivery, and performance of this SAFE, and the consummation of the transactions contemplated hereby, will not (i) result in any violation of or conflict with the Company's Certificate of Incorporation (as amended or restated) or Bylaws (as amended or restated), (ii) result in any violation of, be in conflict with, or constitute a default under, any mater

Section 3(d): Valid Issuance of Securities The shares of Capital Stock issuable upon conversion of this SAFE, when issued in compliance with the provisions of this SAFE, will be duly authorized, validly issued, fully paid, and non-assessable, and will be free and clear of all liens, encumbrances, charges, restrictions, and security interests of any kind, other than restrictions on transfer under this SAFE, under appl

Section 3(e): Capitalization As of the date of this SAFE, the authorized, issued, and outstanding capital stock of the Company, and the securities reserved for future issuance, are as set forth below and in the Company's records, which the Company represents to be accurate and complete in all material respects: (i) Authorized Common Stock: 10,000,000 shares of Common Stock, par value $0.0001 per share, of which 8,600

Section 4(a): Accredited Investor The Investor represents and warrants that it is an "accredited investor" as such term is defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended. The Investor has furnished or will furnish to the Company such information and documentation as the Company may reasonably request to verify the Investor's status as an accredited investor, including

Section 4(b): Investment Experience The Investor has sufficient knowledge and experience in financial and business matters so as to be capable of evaluating the merits and risks of the investment in this SAFE and the securities issuable upon conversion hereof, and has the ability to bear the economic risks of its investment. The Investor has been given the opportunity to ask questions of, and receive answers from, th

Section 4(c): Investment Intent The Investor is acquiring this SAFE and any securities issuable upon conversion hereof for investment for its own account and not with a view toward, or for resale in connection with, the public sale or distribution thereof in violation of the Securities Act. The Investor does not presently have any agreement, plan, or understanding, directly or indirectly, with any person to distribut

Section 4(d): No General Solicitation The Investor acknowledges that the offering of this SAFE was not made to the Investor by means of any form of general solicitation or general advertising, including without limitation (i) any advertisement, article, notice, or other communication published in any newspaper, magazine, website, or similar media, or broadcast over television, radio, or the internet, or (ii) any semi

Section 4(e): Authority The Investor has full legal right, power, and authority to execute, deliver, and perform this SAFE and to consummate the transactions contemplated hereby. The execution, delivery, and performance of this SAFE by the Investor, and the consummation of the transactions contemplated hereby, have been duly authorized by all necessary action on the part of the Investor, including any required approv

Section 4(f): Restrictions on Transfer The Investor acknowledges and understands that this SAFE and any securities issuable upon conversion hereof have not been, and will not be, registered under the Securities Act or under any state securities laws, and are being offered and sold in reliance on federal and state exemptions for transactions not involving a public offering. The Investor further acknowledges that, due

Section 7(a): Amendments and Waivers Any term of this SAFE may be amended, and the observance of any term of this SAFE may be waived (either generally or in a particular instance, and either retroactively or prospectively), only with the written consent of the Company and the Investor. No amendment or waiver of any provision of this SAFE shall be effective unless set forth in a written instrument signed by both the C

Section 7(b): Governing Law This SAFE shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware.

Section 7(c): Disputes; Jurisdiction Any dispute, claim, controversy, or cause of action arising out of or relating to this SAFE or the transactions contemplated hereby, including any question regarding its existence, validity, interpretation, performance, breach, or termination, shall be subject to the exclusive jurisdiction of the Court of Chancery of the State of Delaware (or, if the Court of Chancery lacks subjec

Section 7(d): Entire Agreement This SAFE, together with the schedules attached hereto, constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, representations, warranties, negotiations, correspondence, and communications of the Parties, whether written or oral, with respect to the subject matter hereof. The

Section 7(e): Notices All notices, requests, demands, consents, waivers, and other communications required or permitted to be given under this SAFE shall be in writing and shall be deemed to have been duly given (i) when delivered by hand, (ii) when sent by email (with confirmation of receipt), (iii) one (1) business day after being sent by nationally recognized overnight courier service (with tracking and proof of d

Section 7(f): Severability If any provision of this SAFE, or the application thereof to any person, entity, or circumstance, is found by a court of competent jurisdiction to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision or any other application of this SAFE, and all other provisions and applications of this SAFE shall not be

Section 7(g): Successors and Assigns This SAFE and the rights and obligations hereunder shall be binding upon and inure to the benefit of the Parties and their respective successors, heirs, executors, administrators, legal representatives, and permitted assigns. The Investor may not assign, transfer, pledge, hypothecate, or otherwise dispose of this SAFE or any rights or obligations hereunder, in whole or in part, wi

Section 7(h): Tax Treatment The Company and the Investor agree to treat this SAFE as a variable prepaid forward contract for United States federal income tax purposes and shall not take any position inconsistent with such treatment on any tax return or in any tax proceeding, unless otherwise required by a final determination (as defined in Section 1313(a) of the Internal Revenue Code of 1986, as amended) or by a chan

Section 7(i): Counterparts This SAFE may be executed in two or more counterparts, each of which shall be deemed to be an original, and all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature complying with the U.S. federal ESIGN Act of 2000, the Uniform Electronic Transactions Act, or any other applicable law)

Section 7(j): Waiver of Jury Trial EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHTS TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING, ACTION, CLAIM, COUNTERCLAIM, OR CROSS-CLAIM ARISING OUT OF OR RELATING TO THIS SAFE OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT, OR ATTORNEY OF